1/17/24 17:30 | 1/16/24 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Lunger John | X0 | O | Chief Pa | S.m | -16 | 0.6970 | 0 | -23 | -55 | 19 | D | | | | | | | | | | | | | | |
1/12/24 17:00 | 1/11/24 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Lunger John | X0 | O | Chief Pa | S.m | -8 | 0.8465 | 0 | -9 | -54 | 8 | D | | | | | | | | | | | | | | |
8/1/23 17:00 | 8/1/23 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Lunger John | X0 | O | Chief Pa | S | -3 | 0.9056 | 0 | -3 | -40 | 5 | D | | | | | | | | | | | | | | |
1/17/23 21:17 | 1/17/23 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Lunger John | X0 | O | Chief Pa | S | -8 | 1.86 | 0 | -4 | -38 | 7 | D | | | | | | | | | | | | | | |
1/12/23 21:02 | 1/11/23 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Lunger John | X0 | O | Chief Pa | S.m | -15 | 1.72 | 0 | -9 | -52 | 8 | D | | | | | | | | | | | | | | |
1/4/23 21:01 | 1/4/23 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Lunger John | X0 | O | Chief Pa | S | -2 | 1.69 | 0 | -1 | -39 | 2 | D | | | | | | | | | | | | | | |
8/1/22 21:01 | 8/1/22 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Lunger John | X0 | O | Chief Pa | S | -5 | 1.77 | 0 | -3 | -38 | 5 | D | | | | | | | | | | | | | | |
7/5/22 21:00 | 7/5/22 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Lunger John | X0 | O | Chief Pa | S | -3 | 1.68 | 0 | -2 | -39 | 3 | D | | | | | | | | | | | | | | |
1/18/22 21:03 | 1/18/22 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Lunger John | X0 | O | Chief Pa | S | -14 | 3.19 | 0 | -4 | -37 | 7 | D | | | | | | | | | | | | | | |
1/13/22 21:02 | 1/11/22 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Lunger John | X0 | O | Chief Pa | S.m | -17 | 3.55 | 0 | -5 | -73 | 2 | D | | | | | | | | | | | | | | |
1/5/22 21:06 | 1/4/22 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Lunger John | X0 | O | Chief Pa | S | -4 | 4.06 | 0 | -1 | -38 | 2 | D | | | | | | | | | | | | | | |
8/2/21 17:09 | 8/2/21 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Lunger John | X0 | O | Chief Pa | S | -11 | 3.58 | 0 | -3 | -38 | 5 | D | | | | | | | | | | | | | | |
7/2/21 20:01 | 7/2/21 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Lunger John | X0 | O | Chief Pa | S | -8 | 4.26 | 0 | -2 | -38 | 3 | D | | | | | | | | | | | | | | |
1/19/21 21:01 | 1/19/21 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Lunger John | X0 | O | Chief Pa | S | -25 | 5.67 | 0 | -4 | -37 | 7 | D | | | | | | | | | | | | | | |
1/12/21 21:01 | 1/12/21 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Lunger John | X0 | O | Chief Pa | S | -7 | 6.15 | 0 | -1 | -37 | 2 | D | | | | | | | | | | | | | | |
1/5/21 21:02 | 1/4/21 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Lunger John | X0 | O | Chief Pa | S | -6 | 5.33 | 0 | -1 | -38 | 2 | D | | | | | | | | | | | | | | |
8/4/20 21:02 | 8/3/20 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Lunger John | X0 | O | Chief Pa | S | -45 | 9.25 | 0 | -5 | -37 | 8 | D | | | | | | | | | | | | | | |
1/15/20 20:02 | 1/14/20 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Lunger John | X0 | O | Chief Pa | S | -6 | 5.13 | 0 | -1 | -40 | 2 | D | | | | | | | | | | | | | | |
1/7/20 20:01 | 1/6/20 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Lunger John | PA | O | Chief Pa | S | -1 | 1.20 | 0 | -1 | -41 | 2 | D | | | | | | | | | | | | | | |